Sign in
4

Changes in Ownership

Edesa Biotech, Inc. Filed Acc 0001654954-20-011925

Chief Executive Officer acquired 4,628 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Nijhawan Pardeep Chief Executive Officer 2020-11-05 Option exercise +4,628 $4.00 $18,512 2,128,652 I: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Nijhawan Pardeep Chief Executive Officer 2020-11-05 Option exercise · Common share warrants (Right to buy) −4,628 0 I: show line 2 in the form
Loading xslF345X03/section16.xml…